Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats

Journal of the American Society of Nephrology

Volumn 16, Issue 1, 2005, Pages 97-108

  Shiizaki, Kazuhiro ^a   Negi, Shigeo ^a   Hatamura, Ikuji ^a   Sakaguchi, Toshifumi ^a   Saji, Fumie ^a   Kunimoto, Ken ^a   Mizobuchi, Masahide ^a   Imazeki, Ikuo ^b   Ooshima, Akira ^a   Akizawa, Tadao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; CALCIUM SENSING RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; PARATHYROID HORMONE; VITAMIN D RECEPTOR; ANTINEOPLASTIC AGENT; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM; DRUG DERIVATIVE; MESSENGER RNA;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; ELECTROPHORESIS; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; MALE; NEPHRECTOMY; NICK END LABELING; NONHUMAN; PARATHYROID GLAND; PARATHYROID HYPERPLASIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY HYPERPARATHYROIDISM; STATISTICAL ANALYSIS; UREMIA; ANIMAL; DRUG EFFECT; GENE EXPRESSION; GENETICS; INTRALESIONAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCITRIOL; CALCIUM; GENE EXPRESSION; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS, INTRALESIONAL; MALE; PARATHYROID GLANDS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UREMIA;

EID: 20844462329     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004030236     Document Type: Article

References (37)

1. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001
2. London G, Marty C, Marchais S, Guerin A, Metivier F, de Vernejoul M: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004
3. Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
4. 3 in experimental renal hyperparathyroidism. Kidney Int 44: 1259-1265, 1993
5. Naveh-Many, Rahamimo R, Livin N, Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 1786-1793, 1995
6. WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60: 2109-2117, 2001
7. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92: 1436-1443, 1993
8. Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, Drueke T: Decreased expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51: 328-336, 1997
9. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 46: 1110-1117, 1994
10. Shiizaki K, Hatamura I, Negi S, Narukawa N, Mizobuchi M, Sakaguchi T, Ooshima A, Akizawa T: Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia. Kidney Int 64: 992-1003, 2003
11. Shiizaki K, Negi S, Mizobuchi M, Hatamura I, Narukawa N, Sakaguchi T, Kitabata Y, Sumikado S, Akizawa T: Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 18[Suppl 3]: iii42-iii46, 2003
12. 3, in human serum by liquid chromatography-mass spectrometry. J Chromatogr B 706: 261-267, 1998
13. Vyberg M, Nielsen S: Dextran polymer conjugate two-step visualization system for immunohistochemistry. A comparison of En Vision + with two three-step avidin-biotin techniques. Appl Immunohistochem 6: 3-10, 1998
14. Imanishi Y, Hall C, Sablosky M, Brown E, Arnold A: A new method for in vivo analysis of parathyroid hormone-calcium set point in mice. J Bone Miner Res 17: 1656-1661, 2002
15. Brown E: Four-parameter model of the sigmoid relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56: 572-581, 1983
16. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F: Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 12: 1242-1248, 2001
17. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin K: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136-2143, 1984
18. Levine S, Song M: Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7: 488-496, 1996
19. Brown A, Ritter C, Finch J, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E: The non-calcemic analog of vitamin D, 22-oxacalcitriol (OCT) suppresses parathyroid hormone synthesis and secretion. J Clin Invest 84: 728-732, 1989
20. 3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rat. Kidney Int 50: 34-39, 1996
21. Patel R, Ke Q, Hsu H: Regulation of calcitriol receptor and its mRNA in normal and renal failure rats. Kidney Int 45: 1020-1027, 1994
22. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J, Slatopolsky E: Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol (Lond) 270: F454-F460, 1996
23. Canaff L, Hendy G: Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277: 30337-30350, 2002
24. Lewin E, Garfia B, Recio F, Rodriguez M, Olgaard K: Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 13: 2110-2116, 2002
25. Wyllie A: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980
26. Fukagawa M, Okazaki R, Takano K, Kaname S, Ogata E, Kitaoka M, Harada S, Sekine N, Matsumoto T, Kurokawa K: Regression of parathyroid hypertrophy by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 323: 421-422, 1990
27. Quarles L, Yohay D, Carroll B, Spritzer C, Minda S, Bartholomay D, Lobaugh B: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45: 1710-1721, 1994
28. Jara A, Gonzalez S, Felsenfeld J, Chacon C, Valdivieso A, Jalil R, Chuaqui B: Failure of high dose of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats. Nephrol Dial Transplant 16: 506-512, 2001
29. Canalejo A, Almaden Y, Torregrosa V, Gomez-Villamandos J, Ramos B, Campistol J, Felsenfeld A, Rodriguez M: The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. J Am Soc Nephrol 11: 1865-1872, 2000
30. Wagner D, Wagner N, Sukhatme P, Scholz H: Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells. J Am Soc Nephrol 12: 1188-1196, 2001
31. Puthier D, Bataille R, Barille S, Mellerin M, Harousseau J, Ponzio A, Robillard N, Wijdenes J, Amiot M: Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D derivative, alone or in association with dexamethasone. Blood 88: 4659-4666, 1996
32. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60: 2040-2048, 2000
33. 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res 60: 2304-2312, 2000
34. 3 in prostate cancer. Mol Cancer Ther 1: 667-677, 2002
35. 3 and the retinoid CD 437 in the induction of human melanoma cell apoptosis. Int J Cancer 81: 467-470, 1999
36. Hewison M, Dabrowski M, Vadher S, Faulkner L, Cockerill F, Brickell P, O'Riordan J, Katz D: Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells. J Immunol 156: 4391-4400, 1996
37. Nakagawa K, Sowa Y, Kurobe M, Ozono K, Siu-Caldera ML, Reddy G, Uskokovic M, Okano T: Differential activities of 1α,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids 66: 327-337, 2001